How to stop snoring naturally: what the trials actually show

If you’ve searched for how to stop snoring naturally, you’ve seen the same advice everywhere: tongue exercises, special pillows, nasal strips, sleep on your side. The marketing is confident. The clinical evidence is more complicated. Nasal strips show minimal effects in meta-analysis. Anti-snoring pillows fail in randomized trials. Even orofacial exercises, backed by a Cochrane review, produce modest improvements, not miracle cures. Meanwhile, the interventions with stronger evidence (mandibular advancement devices, strategic weight loss, combination approaches) get less attention. Here’s what the trials actually show about natural snoring solutions.

Why most advice on how to stop snoring naturally overpromises

Search “natural snoring remedies” and you’ll find hundreds of listicles recommending the same five interventions: change your pillow, tape a strip across your nose, do tongue exercises, sleep on your side, lose weight. The problem is not that these interventions lack any supporting evidence. The problem is the gap between what the marketing promises and what the trials measure.

An umbrella review synthesizing systematic reviews of conservative interventions found that while several approaches show statistically significant effects, the clinical significance varies widely.¹⁵ Most meta-analyses report outcomes in terms of the Apnea-Hypopnea Index (AHI, the number of breathing interruptions per hour of sleep), not subjective snoring loudness or partner satisfaction. A product can reduce AHI by 3 events per hour (statistically significant in a trial) while leaving the snoring partner still awake at night (clinically insignificant to the user).

The interventions with the weakest evidence get the most consumer marketing. The interventions with the strongest evidence come with trade-offs that listicles rarely mention. That mismatch drives much of the frustration around natural snoring solutions.

Anti-snoring pillows and nasal strips: minimal evidence, maximum marketing

Anti-snoring pillows dominate Amazon’s top results. The claims are consistent: the pillow’s shape keeps your airway open by adjusting head position. A 2017 randomized controlled trial specifically tested this claim. Researchers gave participants either an anti-snoring pillow designed to elevate and tilt the head or a control pillow, then measured snoring objectively with sleep monitors.⁴ The anti-snoring pillow produced no significant reduction in snoring frequency or intensity compared to the control.

The biomechanics explain why position changes alone often fail. Snoring occurs when airway soft tissues (the soft palate, uvula, tongue base) vibrate during breathing. A 2023 fluid-structure interaction study modeled how sleep posture affects pharyngeal vibration.¹¹ Position does alter airway geometry, but the effect depends on individual anatomy (hyoid bone position, mandible length, neck circumference).¹² A pillow can’t reliably control these variables.

Nasal strips (Breathe Right is the dominant brand) fare slightly better, but only for a narrow patient subset. A 2016 systematic review and meta-analysis pooled data from trials testing external nasal dilators.⁷ The strips produced minimal improvements in AHI for patients with obstructive sleep apnea. The effect was strongest in patients with documented nasal obstruction and weakest in patients with normal nasal patency. If your nose is already clear, the strip adds nothing. If your snoring originates from tongue base collapse or soft palate vibration (the more common causes), widening the nasal valve doesn’t address the obstruction site.

The marketing gap is stark: pillows and strips dominate consumer advertising despite failing in controlled trials or showing effects only in narrow subgroups. The interventions with stronger evidence require more effort or trade-offs, so they appear less often in listicles.

Orofacial exercises show modest effects, not miracle cures

Orofacial myofunctional therapy (tongue and throat exercises designed to strengthen upper airway muscles) has the strongest evidence base among truly non-device interventions. A 2020 Cochrane review, the gold standard for synthesizing clinical evidence, found that myofunctional therapy reduced AHI and snoring frequency in adults with obstructive sleep apnea.¹ The Cochrane authors graded the evidence quality as moderate, meaning the effect is real but the magnitude is modest.

A 2024 meta-analysis quantified the effect size: orofacial exercises reduced AHI by an average of 6.46 events per hour in patients with mild to moderate OSA.³ That’s clinically meaningful for someone with an AHI of 15 (mild OSA), moving them closer to the normal range (AHI under 5). It’s less meaningful for someone with an AHI of 35 (moderate to severe OSA), who would still require additional treatment.

A 2025 network meta-analysis compared different myofunctional therapy protocols.² Supervised programs (with a trained therapist guiding exercises) outperformed unsupervised programs. Telemedicine delivery showed promise: a 2026 controlled study found that app-delivered orofacial exercises remodeled upper airway anatomy measurably in participants who adhered to the protocol.¹⁸

The catch is adherence. Most myofunctional therapy protocols require daily exercises for 8 to 12 weeks, then maintenance exercises indefinitely. A 2025 trial testing combined oropharyngeal and cervical spine exercises found significant AHI reduction, but only in the subset of participants who completed the full protocol.¹⁷ Drop-out rates in myofunctional therapy trials average 20 to 30 percent.

The honest summary: orofacial exercises work for some patients with mild to moderate OSA, if you do them consistently, supervised by someone who knows the technique. They are not a one-week miracle cure. They are not a substitute for CPAP or oral appliances in moderate to severe OSA.

Sleep position matters for some snorers, not all

“Sleep on your side” is universal advice. The evidence is more conditional. Positional therapy works for positional snorers (people whose AHI is significantly worse in the supine position than in lateral positions). Roughly 50 to 60 percent of people with OSA have position-dependent disease.⁵ For them, avoiding supine sleep can cut AHI in half. For the other 40 to 50 percent, position makes little difference.

A 2011 randomized trial tested a positional therapy device (a sensor that vibrated when the wearer rolled onto their back, prompting a position change without fully waking them).⁵ In participants with supine-dependent OSA, the device reduced time spent supine from 50 percent to 10 percent of the night and reduced AHI from 21.3 to 9.5 events per hour. In participants without supine-dependence, the device had no effect on AHI.

The biomechanical reason: gravity. In the supine position, the tongue base falls backward, narrowing the oropharynx. A 2023 computational model showed that supine posture increases soft palate flutter amplitude and pharyngeal vibration frequency compared to lateral posture, but the magnitude varies with individual anatomy.¹¹ If your airway is already compromised by a low hyoid bone position or short mandible, positional therapy alone won’t overcome the anatomical narrowing.

Consumer positional therapy devices (wearable sensors, vibrating alarms, positional pillows, the “tennis ball in a T-shirt” trick) work only if you are actually positional. Without a sleep study to confirm position-dependence, you’re guessing. Clinical practice guidelines now recommend diagnostic confirmation before prescribing positional therapy.¹⁶

How you can stop snoring (or reduce it): the interventions with stronger evidence

The interventions that consistently perform better in trials are also the interventions that require more effort, cost more, or come with side effects. That’s why they appear less often in “10 easy tips” lists, despite stronger evidence.

Mandibular advancement devices (oral appliances)

An umbrella review of systematic reviews found that mandibular advancement devices (MADs, custom-fitted mouthpieces that hold the lower jaw forward during sleep) significantly reduce AHI in adults with mild to moderate OSA.⁸ A 2023 network meta-analysis compared different MAD designs and found that custom-fitted, titratable devices (where you can adjust the degree of jaw advancement) outperform boil-and-bite devices.⁹

A 2024 JAMA trial directly compared MAD alone to combination therapy (MAD plus positional therapy plus nasal dilator).⁶ The MAD alone reduced snoring frequency by 50 percent. The combination therapy reduced it by 62 percent, a modest additional benefit. Both groups showed high adherence (over 80 percent at 3 months).

The trade-offs: MADs cause jaw discomfort in 50 to 70 percent of users during the first 2 weeks. A 2026 systematic review documented longer-term occlusal changes (bite shifts) in 15 to 30 percent of users after 2 years of nightly wear.¹⁰ Most changes are minor, but some patients require orthodontic correction. Custom-fitted MADs cost $500 to $2,000 through a dentist. Over-the-counter consumer versions (like SnoreRX or ZQuiet) cost $50 to $100 but lack the customization and professional fitting that clinical trials test.

Weight loss (if overweight or obese)

Prospective cohort studies show a dose-dependent relationship between weight gain and sleep-disordered breathing. A 2018 study tracking participants over decades found that every 10 percent increase in body weight increased the odds of developing moderate to severe OSA by 32 percent.¹³ Conversely, weight loss reduces AHI, though the effect size varies by individual. A 10 percent weight reduction typically reduces AHI by 20 to 30 percent in patients whose OSA is weight-related.

A 10-year prospective study in women found that leisure-time physical activity independently predicted lower snoring complaints, even after adjusting for BMI.¹⁴ The mechanism is unclear (improved muscle tone, reduced inflammation, better sleep architecture), but the association is consistent across studies.

The reality: weight loss works if excess weight is driving the obstruction. It doesn’t work for patients with anatomical narrowing (retrognathia, enlarged tonsils, low-set hyoid bone) unrelated to adipose tissue. And weight loss is hard. Long-term adherence to diet and exercise interventions averages 20 to 40 percent in clinical trials. That doesn’t mean it’s not worth trying. It means realistic expectations matter.

Combination approaches

A 2026 umbrella review synthesizing meta-analyses of conservative interventions found that multimodal approaches (combining two or more interventions) often outperform single interventions.¹⁵ The JAMA trial mentioned earlier showed combination therapy (MAD plus positional therapy plus nasal hygiene) modestly outperformed MAD alone.⁶ A 2025 trial found that orofacial exercises combined with cervical spine exercises reduced AHI more than orofacial exercises alone.¹⁷

The logic is additive: if your snoring has multiple contributing factors (supine position plus tongue base collapse plus nasal congestion), addressing all three should work better than addressing one. The downside is complexity. Three interventions mean three things to remember, three points of failure, higher cost, and more friction. Adherence drops as intervention complexity rises.

Comparative evidence for natural snoring interventions: what clinical trials measure vs what marketing claims

When snoring signals sleep apnea instead

Snoring and obstructive sleep apnea exist on a continuum. Simple snoring (noise without breathing interruptions) causes social friction but not medical harm. OSA (repeated airway collapse during sleep, causing oxygen desaturation and sleep fragmentation) increases cardiovascular risk, daytime fatigue, and accident rates. The line between them is not always obvious to the person snoring.

Screening questionnaires (like the STOP-BANG or NoSAS score) predict OSA risk better than snoring loudness alone. A 2022 meta-analysis of the NoSAS questionnaire found a sensitivity of 79 percent and specificity of 54 percent for detecting OSA.¹⁹ That means it correctly identifies most people with OSA (sensitivity) but generates many false positives (low specificity). It’s a screening tool, not a diagnostic test.

Current clinical practice guidelines recommend diagnostic sleep testing (polysomnography or home sleep apnea test) for anyone with witnessed apneas (breathing pauses observed by a partner), loud snoring plus daytime sleepiness, or snoring plus hypertension or cardiovascular disease.¹⁶ Self-treating snoring with over-the-counter devices delays diagnosis of OSA in patients who need medical management (CPAP, oral appliances, or surgery).

The key signals that snoring might be OSA:

• Witnessed apneas (your partner sees you stop breathing)
• Gasping or choking during sleep
• Loud snoring plus excessive daytime sleepiness
• Morning headaches
• Snoring plus obesity, hypertension, or cardiovascular disease
• Snoring that persists despite positional therapy or weight loss

If those apply, the appropriate next step is diagnostic testing, not buying another pillow.

Where to buy (if oral appliances fit your situation)

Mandibular advancement devices have the strongest consumer-available evidence among natural snoring interventions. SnoreRX and ZQuiet are over-the-counter MADs in this category. You adjust SnoreRX in 1mm increments to advance the jaw; ZQuiet uses a hinged soft-plastic design that allows some jaw movement during sleep.

The framing matters: clinical trials of MADs typically test custom-fitted devices made by dentists, not boil-and-bite consumer versions. Custom devices allow precise titration and better retention, which likely improves efficacy. Consumer MADs cost $50 to $100 (SnoreRX is $60, ZQuiet is $49.99) compared to $500 to $2,000 for a dentist-fitted device. The trade-off is fit quality and professional oversight. Dental side effects (bite changes, jaw discomfort, tooth movement) occur in 15 to 30 percent of long-term users,¹⁰ and over-the-counter devices lack the monitoring that catches problems early.

If you have mild positional snoring without witnessed apneas or daytime sleepiness, an over-the-counter MAD is a reasonable trial. If you have moderate to severe OSA, hypertension, or cardiovascular disease, a dentist-fitted device with professional follow-up is the standard of care. We are not affiliated with SnoreRX or ZQuiet; we link to them because they fall into the intervention category with the strongest published evidence among consumer products.